SHEPHERD KAPLAN KROCHUK, LLC - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 67 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 22.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHEPHERD KAPLAN KROCHUK, LLC ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2014$225,000
-9.6%
19,127
-36.0%
0.03%
-18.8%
Q4 2013$249,000
+90.1%
29,890
+111.1%
0.03%
+52.4%
Q3 2013$131,000
-5.8%
14,1590.0%0.02%
-22.2%
Q2 2013$139,00014,1590.03%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q3 2013
NameSharesValueWeighting ↓
Abingworth LLP 396,104$400,0000.42%
Ancora Advisors LLC 50,865$51,0000.01%
EAGLE GLOBAL ADVISORS LLC 145,710$146,0000.00%
Acrospire Investment Management LLC 5,200$5,0000.00%
A.R.T. Advisors, LLC 57,954$57,0000.00%
Renaissance Technologies 876,100$876,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 4,600$5,0000.00%
Cutler Group LLC / CA 11,048$11,0000.00%
PANAGORA ASSET MANAGEMENT INC 133,846$134,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$46,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders